A Comprehensive Approach Toward Novel Serum Biomarkers for Benign Prostatic Hyperplasia: The MPSA Consortium

PURPOSE: Clinical benign prostatic hyperplasia (BPH) is primarily diagnosed based on a diverse array of progressive lower urinary tract symptoms (LUTS) and is likely distinct from histological BPH, which is detected by the presence of non-malignant proliferation of prostate cells but may or may not...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Mullins, Chris, Lucia, M. Scott, Hayward, Simon W., Lee, Jeannette Y., Levitt, Jonathan M., Lin, Victor K., Liu, Brian C.-S., Chinnaiyan, Arul M., Rubin, Mark A., Slawin, Kevin, Star, Robert A., Getzenberg, Robert H.
Formato: Artigo
Idioma:Inglês
Publicado: 2008
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3105378/
https://ncbi.nlm.nih.gov/pubmed/18280515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2007.11.049
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares